HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Featured / [Book Release] Value-Based Drug Pricing Guide on Flawed $500 Billion Industry Available for Preorder

[Book Release] Value-Based Drug Pricing Guide on Flawed $500 Billion Industry Available for Preorder


The Right Price
by Peter Neumann, ScD, Joshua Cohen, PhD, and Daniel Ollendorf, PhD, is available for preorder. It will be released on May 1st. Dr. Peter Neumann serves as Director of CEVR (the Center for the Evaluation of Value and Risk in Health) at Tufts Medical Center with Dr. Joshua Cohen as Deputy Director of CEVR and Dr. Daniel Ollendorf as Director of Value Measurement and Global Health Initiatives at CEVR. The authors draw on their collective backgrounds, including Dr. Ollenforf’s role as ICER’s Chief Scientific Officer and Dr. Neumann’s role on the Congressional Budget Office’s health policy advisory board, to clearly explain the challenges facing industries directly and indirectly related to the prescription drug market, prescription drug pricing, and mechanisms used to assess value. They also propose solutions.

According to the authors, “The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide on pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry, and explains why simple solutions like price controls and the importation of cheaper drugs from other countries will not work.” They further note, “With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.” Read more here.

(Source: Oxford University Press, 2021)



You might also be interested in:

  • What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
  • How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020
  • New Program in Pharmaceutical Value Assessment and… 01/22/2021
  • [Webinar] How can VA/HTA Inform Policy Interventions and… 10/15/2020
  • Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
  • ICER Announces New Governance Board Members in Push to Improve… 03/22/2021
  • Patient Drug Costs Increased as Health Plans Promote… 08/07/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

How Payers Can Outpace Market Competition

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute